by Roche Molecular Diagnostics The FDA has approved the COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, v2.0, a dual-PCR target HIV-1 viral load test from Roche Molecular Diagnostics. The FDA has ...

Basel, 15 June 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the cobas SARS-CoV-2 Duo for ...

reliable and accurate COVID-19 PCR testing beyond the EUA period. Based on continuous analysis performed since the onset of the pandemic, all Roche molecular tests, including the cobas SARS-CoV-2 ...

The COBAS TaqMan HIV-1 Test v2.0 for use with the High Pure System enables labs to combine an FDA-approved process for manual specimen preparation with an automated real-time PCR analyzer for ...

(RTTNews) - Roche Thursday announced the U.S ... serving as an early predictor of an impending infection. A urine sample stabilised in cobas PCR Media allows the integrity of urine results ...